|
|
| | Palbociclib Impurity 91 Basic information |
| Product Name: | Palbociclib Impurity 91 | | Synonyms: | Palbociclib Impurity 91;Palbociclib impurity APMP;Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-2-[[5-[(2-aminoethyl)amino]-2-pyridinyl]amino]-8-cyclopentyl-5-methyl-;6-Acetyl-2-[5-(2-amino-ethylamino)-pyridin-2-ylamino]-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one;2-Aminoethyl-amino Palbociclib;6-acetyl-2-((5-((2-aminoethyl)amino)pyridin-2-yl)amino)-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one? (Palbociclib Impurity）;PalbociclibimpurityAPMPTrihydrochloride;Palbociclib impurity 02 | | CAS: | 571191-15-6 | | MF: | C22H27N7O2 | | MW: | 421.5 | | EINECS: | | | Product Categories: | | | Mol File: | 571191-15-6.mol |  |
| | Palbociclib Impurity 91 Chemical Properties |
| Boiling point | 694.4±65.0 °C(Predicted) | | density | 1.350±0.06 g/cm3(Predicted) | | pka | 9.22±0.10(Predicted) |
| | Palbociclib Impurity 91 Usage And Synthesis |
| Uses | 2-Aminoethyl-amino Palbociclib is an impurity of Palbociclib (also known as compound number PD-0332991) (P139900), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. 2-Aminoethyl-amino Palbociclib can be used to prepare drugs for treating bacterial infections and breast cancer. |
| | Palbociclib Impurity 91 Preparation Products And Raw materials |
|